Position Summary
We are seeking a highly motivated Vice President, CMC Process Sciences, who will oversee the establishment and execution of CMC development plans and strategies for cell and gene therapy products in a state-of-the-art multi-product cell therapy manufacturing facility (IDMO Smart Factory) that will be utilized to manufacture autologous and allogeneic cell therapy products.
This individual will oversee CMC Operations, Process Development, Analytical Development and MS&T to develop phase appropriate processes and procedures required to support our partners through the launch, ramp-up, and production within our state-of-the-art multi-product cell therapy manufacturing facility.
This individual will be responsible for providing CMC leadership for products at various stages of development and serve in a key leadership role that will engage with internal and external stakeholders within our IDMO Business to ensure alignment with customer needs and business strategies. As such, the role will require proven leadership experience to drive effective communication, coordination, and collaboration across relevant cross functional groups to support the development, tech transfer, GMP Operations, and lifecycle management of cell and gene therapy products manufactured within our facilities.
This is a multidisciplinary role & this individual will need the ability to interface with all levels of the organization, including Operations, Quality, Supply Chain, Warehouse, Training, Engineering/Facilities, HS&E, and Finance.
The successful candidate should enjoy working in a fast-paced, mission-driven environment, and be prepared to tackle a broad selection of challenges as the company grows.
This is Cellares
Cellares is the first Integrated Development and Manufacturing Organization (IDMO) and takes an Industry 4.0 approach to mass manufacturing the living drugs of the 21st century. The company is both developing and operating integrated technologies for cell therapy manufacturing to accelerate access to life-saving cell therapies. The company’s Cell Shuttle integrates all the technologies required for the entire manufacturing process in a flexible and high-throughput platform that delivers true walk-away, end-to-end automation. Cell Shuttles will be deployed in Cellares’ Smart Factories around the world to meet total patient demand for cell therapies at global scale. Partnering with Cellares enables academics, biotechs, and pharma companies to accelerate drug development and scale out manufacturing, lower process failure rates, lower manufacturing costs, and meet global patient demand.
The company is headquartered in South San Francisco, California with its commercial-scale IDMO Smart Factory in Bridgewater, New Jersey. The company is backed by world-class investors and has raised over $355 million in financing.
Leveling will be based on overall experience, education, and demonstration of knowledge throughout the interview process.